Form 4: National Healthcare Corp Director Richard F. LaRoche Jr. Reports Option Grant
SEC Form 4
Director Richard F. LaRoche Jr. reports the grant of stock options and updates to previously reported option expiration dates.
Summary
- Richard F. LaRoche Jr., a director of National Healthcare Corp (NHC), filed a Form 4 on May 9, 2024, reporting changes in beneficial ownership.
- The report details the grant of 7,500 stock options to LaRoche on May 9, 2024, at an exercise price of $96.03, exercisable from May 9, 2025, and expiring on May 8, 2029.
- The filing also corrects the expiration dates of previously reported option grants from 2021 and 2022.
- LaRoche directly and indirectly owns common stock through various means, including personal holdings, ROTH IRA, and family partnerships.
Sentiment
Score: 7
Explanation: The sentiment is neutral to slightly positive. The granting of options is a standard practice, and the correction of previous errors indicates a commitment to accuracy.
Positives
- The grant of stock options aligns the director's interests with those of the shareholders.
- Correction of previously reported data ensures transparency and accuracy.
Industry Context
Stock option grants are a common practice in the healthcare industry to incentivize and retain key personnel.
Comparison to Industry Standards
- Comparing the option grant to similar companies in the healthcare sector would require analyzing the size of the grant relative to the company's market capitalization and the director's overall compensation package.
- Companies like Brookdale Senior Living and Five Star Senior Living also utilize stock options as part of their executive compensation plans.
- Industry benchmarks for option grants typically consider factors such as company performance, individual contributions, and market conditions.
Stakeholder Impact
- The stock option grant could potentially impact shareholders by diluting equity if the options are exercised.
- The grant incentivizes the director to work towards increasing shareholder value.
Key Dates
| Date | Description |
|---|---|
| 05/07/2021 | Date exercisable for 2020 Grant |
| 05/06/2022 | Date exercisable for 2021 Grant |
| 05/05/2023 | Date exercisable for 2022 Grant |
| 05/04/2024 | Date exercisable for 2023 Grant |
| 05/09/2024 | Date of transaction and filing of Form 4; Date exercisable for 2024 Grant |
| 05/06/2025 | Expiration date for 2020 Grant |
| 05/05/2026 | Expiration date for 2021 Grant |
| 05/04/2027 | Expiration date for 2022 Grant |
| 05/03/2028 | Expiration date for 2023 Grant |
| 05/08/2029 | Expiration date for 2024 Grant |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.